London-primarily based LabGenius, which makes use of AI and &quotrobotic automation&quot for protein drug discovery, raises $10M Series A led by Lux Capital and Apparent Ventures (Steve O&#039Hear/TechCrunch)

[ad_1]


Steve O’Hear / TechCrunch:

London-primarily based LabGenius, which makes use of AI and &ldquorobotic automation&rdquo for protein drug discovery, raises $10M Series A led by Lux Capital and Apparent Ventures&nbsp &mdash&nbsp LabGenius, a London-primarily based startup applying AI and &ldquorobotic automation&rdquo to protein drug discovery, has raised $10 million in Series A funding.



[ad_2]

Latest posts